Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jung-Fu Chen is active.

Publication


Featured researches published by Jung-Fu Chen.


Journal of Bone and Mineral Metabolism | 2014

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary

Jawl-Shan Hwang; Ding-Cheng Chan; Jung-Fu Chen; Tien-Tsai Cheng; Chih-Hsing Wu; Yung-Kuei Soong; Keh-Sung Tsai; Rong-Sen Yang

Osteoporosis is recognized as a major public health problem worldwide and in Taiwan. However, many patients with osteoporotic fractures do not receive appropriate assessments or treatments. This guideline, proposed by the Taiwanese Osteoporosis Association, is to serve as a quick reference for healthcare providers to improve the assessment of osteoporosis and development of optimal strategies for osteoporotic management in Taiwan. To review and update osteoporosis management, the guideline is constituted with Taiwan-specific osteoporosis epidemiological data, medication protocols, and the 10-year FRAX®. The guideline is based on evidence-based medicine and public health considerations. Recommendations are not limited to the reimbursement regulations permitted by the National Health Insurance of Taiwan.


Journal of Clinical Densitometry | 2014

Consensus of Official Position of IOF/ISCD FRAX Initiatives in Asia-Pacific Region

Chih-Hsing Wu; Eugene McCloskey; Joon Kiong Lee; Akira Itabashi; Richard L. Prince; Wei Yu; Julie Li-Yu; Siok Bee Chionh; Yanling Zhao; Chan Soo Shin; Tirtarahardja Gunawan; Keh-Sung Tsai; Poon-Ung Chieng; Sheng-Pin Changlai; Ding-Cheng Chan; Jung-Fu Chen; S. Bobo Tanner; Didier Hans; John A. Kanis; Yin-Fan Chang; Zih-Jie Sun; Rong-Sen Yang

The fracture risk assessment tool (FRAX(®)) has been developed for the identification of individuals with high risk of fracture in whom treatment to prevent fractures would be appropriate. FRAX models are not yet available for all countries or ethnicities, but surrogate models can be used within regions with similar fracture risk. The International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) are nonprofit multidisciplinary international professional organizations. Their visions are to advance the awareness, education, prevention, and treatment of osteoporosis. In November 2010, the IOF/ISCD FRAX initiative was held in Bucharest, bringing together international experts to review and create evidence-based official positions guiding clinicians for the practical use of FRAX. A consensus meeting of the Asia-Pacific (AP) Panel of the ISCD recently reviewed the most current Official Positions of the Joint Official Positions of ISCD and IOF on FRAX in view of the different population characteristics and health standards in the AP regions. The reviewed position statements included not only the key spectrum of positions but also unique concerns in AP regions.


Public Health Nutrition | 2009

Final Declaration of the Asian Metaforum on the Role of Vitamin D and the Management of Osteoporosis

Siew-Pheng Chan; Jung-Fu Chen; Leung-Wing Chu; Dai-Phi Van; David Hosking; Tai-Pang Ip; Leonard Koh; Annie Kung; Ning-Sheng Lai; Edith Lau; Joon-Kiong Lee; Rattana Leewattana; Yong-ki Min; Nguyen-Dac Nghia; Ongphiphadhanakul Boonsong; Hyoung-moo Park; Johann Ringe; Bambang Setyohadi; Chan-Soo Shin; Suppasin Soontrapa; Nimit Taechakraichana; Fachry Tanjung; Dohar Tobing; Keh-Sung Tsai; Jean Woo; Rong-Sen Yang

BACKGROUND Vitamin D is essential for Ca absorption, prevention of falls and fracture, and maintenance of muscle strength and balance. Lack of awareness of the importance of vitamin D in bone health is common in Asia. OBJECTIVE To define key statements, objectives and actions for improving osteoporosis management and vitamin D inadequacy in Asia. RESULTS AND CONCLUSION This declaration was jointly produced by specialists at the Asia Metaforum on the Role of Vitamin D and the Management of Osteoporosis, held in September 2006 in Hong Kong, to define actions to prevent vitamin D insufficiency in Asia. Although developed specifically for Asia, some or all of these statements may be applicable to other regions of the world.


Diabetic Medicine | 2016

Long-term use of acarbose and CV Event: confusing finding from mega data bank

Chih-Hsing Wu; Chen‐Jung Shen; Kun‐Ling Wu; Zih-Jie Sun; Ming‐Fong Chang; Jung-Fu Chen; Shih-Te Tu

For the four years from 2009–2010 to 2012–2013 the number of people with Type 2 diabetes receiving the care process of recording the urine albumin-to-creatinine ratio variedbetween 73.9% and 77.5%. The number increased in 2013–2014 to 84.4%, but decreased significantly in 2014–2015 to 74.6%. The QOF indicator incentivizing the recording of albumin-tocreatinine ratio was retired from 1 April 2014.


Archives of Osteoporosis | 2018

Correction to: Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region

Ding-Cheng Chan; Lo-Yu Chang; Kristina Åkesson; Paul Mitchell; Chung-Hwan Chen; E. Michael Lewiecki; Joon Kiong Lee; Tang Ching Lau; Thawee Songpatanasilp; Kin Bong Lee; Kwang Joon Kim; Jung-Fu Chen; Ko-En Huang; Yih-Lan Gau; Yin-Fan Chang; Peter R. Ebeling; Weibo Xia; Wei Yu; Atsushi Suzuki; Fen Lee Hew; Leilani B. Mercado-Asis; Yoon-Sok Chung; Keh-Sung Tsai; Gau-Tyan Lin; Rong-Sen Yang; Chih-Hsing Wu

In this article the name of the sixth author, E. Michael Lewiecki was rendered incorrectly. The publisher regrets this error and apologizes for the inconvenience caused.


Annals of the Rheumatic Diseases | 2016

FRI0197 Time Lag of Improvement in Synovial Hypertrophy Compared To Rapid Response in Power Doppler Synovial Vascularity in Post-Adalimumab Rheumatoid Arthritis

Y.-C. Chen; Jung-Fu Chen; Tien-Tsai Cheng

Background In previous studies, the patients achieved greater disease control by adalimumab at 24 weeks, this response was maintained over the next 24 weeks1, however, we could not found the characteristic in image to confirm the clinical presentations. Objectives This study aimed to validate the use of power Doppler ultrasonography (PDUS) for evaluating synovial vascularity and synovial hypertrophy for synovitis in patients with rheumatoid arthritis (RA) treated with adalimumab. Methods The synovial disease activity and vascularity of RA on both wrists (radio-carpal joint) were assessed using GS and PDUS to derive the composite US scores based on abnormal counts and severity. The relationship between each measure was determined. Results The 71 patients who received adalimumab therapy had significantly decreased DAS28, ESR, and CRP. After one month, PD score decreased and then remained low for 12 months. Synovial hypertrophy did not change until 3–6 months after, when it started to improve (p=0.017). By multivariate analysis, sex, age, BMI, and DAS28 did not lead to any difference between synovial hypertrophy and PDUS changes (p=0.498). Conclusions Composite US markers of synovial hypertrophy correlate significantly to the DAS28 score and ESR/CRP in adult RA. The time needed for synovial hypertrophy to decrease may be up to 3–6 months after adalimumab therapy. Using ultrasound Doppler measurements predict success of treatment with anti-TNF-alpha has been a trend in monitoring biological therapy in patients with RA References Keystone EC, et al. Arthritis and rheumatism. May 2004;50(5):1400–1411. Disclosure of Interest None declared


Journal of Clinical Densitometry | 2011

Who Can Pass the ISCD Professional Certification Course? The 8-Yr Experience in Taiwan

Man-Chun Wu; Chih-Hsing Wu; Yung-Kuei Soong; Ruey-Mo Lin; Tzay-Shing Yang; Jung-Fu Chen; Keh-Sung Tsai

The International Society for Clinical Densitometry (ISCD) launched the professional certification course in early 1996 and was introduced to Taiwan by the Taiwanese Osteoporosis Association in 2002. Disclosing the associated factors of passing the certification examination would be valuable to advance the teaching skill of faculties and clinical excellence of professionals. From June 2002 to July 2009, 732 attendees (male/female=621/111) of 12 professional certification courses (11 courses delivered in Chinese) were enrolled for analysis. All subjects were asked to complete a questionnaire including demographics and professional experience at the time of course registration. After certification examination, subjects were dichotomized as either pass or fail group for analyzing the determinants of pass rate statistically. The average pass rate of the 12 examinations was 75.3% (n=551). In univariate analysis, the age (p<0.001) and hospital level (p<0.001) showed significant differences between the pass and fail groups. However, in the multivariate logistic analysis, only the age (odds ratio [OR]=0.907, 95% confidence interval [CI]: 0.867-0.949, p<0.001) and clinical experience (attending physician vs resident: OR=3.210, 95% CI: 1.215-8.485, p=0.019) were the independent determinants for passing the course. Professionals who are relatively younger or attending physicians have higher pass rate of ISCD course in Taiwan. The fact that only limited predisposing factors might influence the pass rate reflects the efficient design of course delivering. For any knowledge level of professionals who have interest in the excellence of osteoporosis diagnosis and management, the ISCD course is recommended.


Osteoporosis International | 2006

Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis

Jawl-Shan Hwang; Shih-Te Tu; Tzay-Shing Yang; Jung-Fu Chen; C. J. Wang; Keh-Sung Tsai


Osteoporosis International | 2013

Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan

Yung-Kuei Soong; Keh-Sung Tsai; Hsuan Ying Huang; Rong-Sen Yang; Jung-Fu Chen; Ping Ching Wu; Ko-En Huang


Journal of Bone and Mineral Metabolism | 2011

The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis

Jawl-Shan Hwang; Lin-Show Chin; Jung-Fu Chen; Tzay-Shing Yang; Po-Quang Chen; Keh-Sung Tsai; Ping Chung Leung

Collaboration


Dive into the Jung-Fu Chen's collaboration.

Top Co-Authors

Avatar

Keh-Sung Tsai

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Chih-Hsing Wu

National Cheng Kung University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rong-Sen Yang

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Ding-Cheng Chan

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Tzay-Shing Yang

National Yang-Ming University

View shared research outputs
Top Co-Authors

Avatar

Yin-Fan Chang

National Cheng Kung University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Y.-C. Chen

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge